Doctor Evidence
Dr.Evidence provides an AI-enabled landscape intelligence platform for the life sciences industry. Their platform helps pharmaceutical and biotechnology companies, from top-tier enterprises to emerging ones, to gain efficiencies across clinical, regulatory, labeling, safety, market access, and medical affairs teams. By combining human domain expertise with AI, Dr.Evidence enables users to rapidly answer critical questions about the competitive landscape, regulatory documents, clinical trials, and scientific literature. The platform's key products include Label Intelligence, Regulatory Intelligence, and Literature Search, which streamline access to and analysis of complex data. The company leverages over 25 large language, machine learning, and natural language processing models to process millions of scientific literature citations, labels, clinical trials, and other data points, offering a significant step forward in driving efficiencies and accelerating time-to-market.
Doctor Evidence
Dr.Evidence provides an AI-enabled landscape intelligence platform for the life sciences industry. Their platform helps pharmaceutical and biotechnology companies, from top-tier enterprises to emerging ones, to gain efficiencies across clinical, regulatory, labeling, safety, market access, and medical affairs teams. By combining human domain expertise with AI, Dr.Evidence enables users to rapidly answer critical questions about the competitive landscape, regulatory documents, clinical trials, and scientific literature. The platform's key products include Label Intelligence, Regulatory Intelligence, and Literature Search, which streamline access to and analysis of complex data. The company leverages over 25 large language, machine learning, and natural language processing models to process millions of scientific literature citations, labels, clinical trials, and other data points, offering a significant step forward in driving efficiencies and accelerating time-to-market.